Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.281
Neutral
RSI(14)
54.973
Neutral
STOCH(KDJ)(9,3,3)
33.336
Sell
ATR(14)
1.108
Low Volatility
CCI(14)
-37.158
Neutral
Williams %R
71.098
Sell
TRIX(12,20)
0.994
Sell
StochRSI(14)
0.000
Oversold
Astrana Health Inc
ASTH29.700USD
-1.120-3.63%
Close 09/05, 16:00（ET）Quotes delayed by 15 min
1.46BMarket Cap
57.78P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-09-05Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
43.889
Target Price
+42.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 77.82% year-on-year.
Overvalued
The company’s latest PE is 57.15, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 37.72M shares, decreasing 5.96% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 4.82M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.83.
Financial Health
Currency: USD Updated：2025-09-05The company's current financial score is 8.03, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 620.39M, representing a year-over-year increase of 53.43%, while its net profit experienced a year-over-year increase of 54.89%.
Score
Financials
9.65
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
8.39
Operational Efficiency
7.47
Growth Potential
6.52
Shareholder Returns
8.11
Company Valuation
Currency: USD Updated：2025-09-05The company’s current valuation score is 4.80, which is higher than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 60.05, which is -39.47% below the recent high of 36.35 and 47.76% above the recent low of 31.37.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 25/280
No Data
Earnings Forecast
Currency: USD Updated：2025-09-05The company’s current earnings forecast score is 8.36, which is higher than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Astrana Health Inc is 44.00, with a high of 54.00 and a low of 35.00.
Score
Support & Resistance
No Data
Analyst Rating
Based on
11
analysts
Buy
Current Rating
43.889
Target Price
+42.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
69
Total
7
Median
8
Average
Company name
Ratings
Analysts
Astrana Health Inc
ASTH
11
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-09-05The company’s current price momentum score is 9.59, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 34.55 and the support level at 24.53, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
31.012
Sell
MA10
30.850
Sell
MA20
30.080
Sell
MA50
26.327
Buy
MA100
27.102
Buy
MA200
30.937
Sell
Institutional Confidence
Currency: USD Updated：2025-09-05The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 75.56%, representing a quarter-over-quarter decrease of 4.25%. The largest institutional shareholder is The Vanguard, holding a total of 4.82M shares, representing 9.66% of shares outstanding, with 0.97% decrease in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
Allied Physicians of California, A Professional Medical Corporation
BlackRock Institutional Trust Company, N.A.
State Street Global Advisors (US)
Lam (Thomas S)
Sim (Brandon)
Sim (Kenneth T)
Dimensional Fund Advisors, L.P.
Fidelity Management & Research Company LLC
Geode Capital Management, L.L.C.
1
2
Risk Assessment
Currency: USD Updated：2025-09-05The company's beta value is 0.84. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.84
VaR
+5.43%
240-Day Maximum Drawdown
+65.69%
240-Day Volatility
+58.41%
Return
Best Daily Return
60 days
+30.85%
120 days
+30.85%
5 years
+30.85%
Worst Daily Return
60 days
-9.60%
120 days
-11.14%
5 years
-26.82%
Sharpe Ratio
60 days
+1.20
120 days
+0.36
5 years
+0.47
Risk Assessment
Maximum Drawdown
240 days
+65.69%
3 years
+65.69%
5 years
+82.03%
Return-to-Drawdown Ratio
240 days
-0.74
3 years
-0.04
5 years
+0.15
Skewness
240 days
+0.05
3 years
+0.22
5 years
+0.31
Volatility
Realised Volatility
240 days
+58.41%
5 years
+61.19%
Standardised True Range
240 days
+5.56%
5 years
+8.10%
Downside Risk-Adjusted Return
120 days
+62.32%
240 days
+62.32%
Maximum Daily Upside Volatility
60 days
+80.67%
Maximum Daily Downside Volatility
60 days
+42.99%
Liquidity
Average Turnover Rate
60 days
+0.74%
120 days
+0.67%
5 years
--
Turnover Deviation
20 days
+82.53%
60 days
+37.95%
120 days
+26.16%
Peer Comparison
Currency: USD Updated：2025-09-05Astrana Health Inc
ASTH
7.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
